These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8697888)

  • 41. Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.
    Ito T; Matsumoto M; Nishino T
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1522-5. PubMed ID: 7492097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.
    Eckart RE; Hospenthal DR; Fishbain JT
    Pharmacotherapy; 2000 May; 20(5):589-92. PubMed ID: 10809347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.
    Nicolau DP; Freeman CD; Nightingale CH; Coe CJ; Quintiliani R
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1515-8. PubMed ID: 7979281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Galani L; Pefanis A; Sakka V; Iliopoulos D; Donta I; Triantafyllidi H; Skiadas I; Karayiannakos P; Giamarellou H
    Int J Antimicrob Agents; 2009 Jan; 33(1):65-9. PubMed ID: 18818055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
    Antimicrob Agents Chemother; 1998 Apr; 42(4):981-3. PubMed ID: 9559828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Chambers HF
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
    Patel MV; De Souza NJ; Gupte SV; Jafri MA; Bhagwat SS; Chugh Y; Khorakiwala HF; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
    Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML; de Górgolas M
    J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Leclercq R; Duval J; Carbon C
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Caillon J; Grossi O; Le Mabecque V; Miegeville AF; Bugnon D; Batard E; Potel G
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2547-9. PubMed ID: 16801442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a mouse model of induced Staphylococcus aureus infective endocarditis.
    Gibson GW; Kreuser SC; Riley JM; Rosebury-Smith WS; Courtney CL; Juneau PL; Hollembaek JM; Zhu T; Huband MD; Brammer DW; Brieland JK; Sulavik MC
    Comp Med; 2007 Dec; 57(6):563-9. PubMed ID: 18246868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
    Balzli CL; Caballero AR; Tang A; Weeks AC; O'Callaghan RJ
    J Cataract Refract Surg; 2010 Dec; 36(12):2160-7. PubMed ID: 21111321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
    Bayer AS; Li C; Ing M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Resistance and new antibiotic strategies. New antistaphylococcal antibiotics].
    Bergogne-Bérézin E
    Presse Med; 2000 Dec; 29(37):2023-7. PubMed ID: 11155724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
    Sullam PM; Täuber MG; Hackbarth CJ; Chambers HF; Scott KG; Sande MA
    Antimicrob Agents Chemother; 1985 May; 27(5):685-7. PubMed ID: 3860185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.